Hookipa Biotech AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Hookipa Biotech AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10682
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hookipa Biotech AG (Hookipa) is a biotechnology company that develops vaccines and next-generation immunotherapeutics for the prevention and treatment of cancer and infectious diseases. The company’s lead product candidate include HB101 vaxwave, a vaccine under development for immunization against cytomegalovirus; HB201 for the treatment of human papilloma virus, and others. It uses its proprietary immunotherapy technology vaxwave that is used to develop a new class of cancer immunotherapeutics and vaccines. Hookipa’s vaxwave uses a replication-defective viral vector to develop prophylactic and therapeutic vaccines to treat cancer and infectious diseases. The company’s vaxwave-based immunotherapy can be applied repeatedly to enhance the immune system against diseases where B-cell and T-cell immune responses are required. Hookipa is headquartered in Vienna, Austria.

Hookipa Biotech AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hookipa Biotech AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Hookipa Biotech Raises USD58.8 Million in Series C Financing 10
Hookipa Biotech Raises US$27 Million In Series B Financing 12
Licensing Agreements 14
Gilead Sciences Enters into Licensing Agreement with Hookipa Biotech 14
Hookipa Biotech AG – Key Competitors 15
Hookipa Biotech AG – Key Employees 16
Hookipa Biotech AG – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Oct 18, 2017: Dr. Jan van de Winkel Joins Hookipa as Chairman of its Board of Directors 18
Apr 19, 2017: Reinhard Kandera Appointed Chief Financial Officer of Hookipa Biotech 19
Apr 19, 2017: Hookipa Biotech appoints CFO 20
Product News 21
May 26, 2017: Hookipa Biotech Announces Nature Communications Publication Showing TheraT Turns Cold Tumors Hot 21
05/15/2018: New Insights into Hookipa’s TheraT Replicating Viral Vector Platform Published in Immunity 22
03/06/2017: Dr Igor Matushansky Appointed Global Head, Research and Development of Hookipa Biotech 23
01/09/2017: Hookipa Biotech Announces Publication in Clinical and Vaccine Immunology Highlighting Vaxwave as an Effective Viral Vector for Vaccination against Congenital Cytomegalovirus Infections 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Key Facts 2
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hookipa Biotech AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hookipa Biotech AG, Deals By Therapy Area, 2012 to YTD 2018 8
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Hookipa Biotech Raises USD58.8 Million in Series C Financing 10
Hookipa Biotech Raises US$27 Million In Series B Financing 12
Gilead Sciences Enters into Licensing Agreement with Hookipa Biotech 14
Hookipa Biotech AG, Key Competitors 15
Hookipa Biotech AG, Key Employees 16

List of Figures
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Hookipa Biotech AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Greystone Logistics Inc (GLGI):企業の財務・戦略的SWOT分析
    Summary Greystone Logistics Inc (Greystone Logistics) is a chemical company that manufactures plastic pallet products. The company provides products such as no rods pallet, rods pallet, beverage pallet, nestable pallet, monoblock pallet, rackable pallet, picture frame web-top pallets, stackable pall …
  • Flint Group SA:企業の戦略的SWOT分析
    Flint Group SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Chaucer Holdings Limited:企業の戦略・SWOT・財務情報
    Chaucer Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Chaucer Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Tampa Electric Co-エネルギー分野:企業M&A・提携分析
    Summary Tampa Electric Company (TEC), a subsidiary of Emera Inc., is an energy utility. It conducts the generation, purchase, transmission, distribution and sale of electricity and the distribution, purchase and sale of natural gas in Florida. The service area for electric operations covers West Cen …
  • Amgen Inc (AMGN):企業の財務・戦略的SWOT分析
    Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • EnGeneIC Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary EnGeneIC Ltd (EnGeneIC) is a biopharmaceutical company that develops drugs and other therapeutic molecules. The company develops nanocell platform used as a platform for the creation of custom therapies for cancer. Its cyto-immunotherapy platform releases concentrations of RNA-interference m …
  • XPO Logistics, Inc.:企業のM&A・事業提携・投資動向
    XPO Logistics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's XPO Logistics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Royal DSM NV (DSM):医療機器:M&Aディール及び事業提携情報
    Summary Royal DSM NV (DSM) is a science-based company with focus on materials, health and nutrition. It produces vitamins, carotenoids, nutritional lipids and other ingredients; specialty plastics; and fiber and resins solutions. DSM develops materials for medical devices and clean energy from crop …
  • RCR Tomlinson Ltd (RCR):企業の財務・戦略的SWOT分析
    RCR Tomlinson Ltd (RCR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Confused.Com Limited:企業の戦略・SWOT・財務分析
    Confused.Com Limited - Strategy, SWOT and Corporate Finance Report Summary Confused.Com Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Vifor Pharma AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Vifor Pharma AG (Vifor Pharma) a subsidiary of Galenica Ltd is a healthcare service provider that discovers, develops, manufactures, and commercializes prescription and over the counter pharmaceutical products for the treatment of iron replacement therapy. The company offers products for tre …
  • Fronius International GmbH:企業の戦略的SWOT分析
    Fronius International GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • M3 Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary M3 Biotechnology Inc (M3 Biotech) is a therapeutics company that concentrates on novel platform of pharmaceuticals that modifies growth-factor systems. The company provides therapies primarily for the treatment of neurodegenerative diseases. It develops small molecule modulators with a conce …
  • Wagamama Limited :企業の戦略・SWOT・財務情報
    Wagamama Limited - Strategy, SWOT and Corporate Finance Report Summary Wagamama Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Anadarko Petroleum Corp (APC):企業の財務・戦略的SWOT分析
    Anadarko Petroleum Corp (APC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • ATI Physical Therapy-製薬・医療分野:企業M&A・提携分析
    Summary ATI Physical Therapy (ATI) is a healthcare service provider that offers therapy services. The center offers therapy services such as physical therapy, workers' comp rehab, sports therapy, hand therapy, women's health, specialty therapies, home health and complimentary injury screening servic …
  • ConforMIS Inc (CFMS):企業の財務・戦略的SWOT分析
    Summary ConforMIS Inc (ConforMIS) is a medical technology company that manufactures, develops, and markets joint replacement implants. The company’s knee replacement implant products include iTotal CR a cruciate-retaining product, iTotal PS a posterior cruciate ligament substituting product, and iDu …
  • DAMAC Real Estate Development Ltd:企業の戦略・SWOT・財務情報
    DAMAC Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report Summary DAMAC Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Kia Motors Corporation:企業の戦略・SWOT・財務情報
    Kia Motors Corporation - Strategy, SWOT and Corporate Finance Report Summary Kia Motors Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Monadelphous Group Ltd (MND):企業の財務・戦略的SWOT分析
    Monadelphous Group Ltd (MND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆